| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Joshua M Hare | |
| Steven P Schulman | |||
| Andrew J Boyle | |||
| Peter Oettgen | |||
| P2860 | cites work | Spontaneous human adult stem cell transformation. | Q53358878 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 353-358 | |
| P577 | publication date | 2006-07-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Cardiac Stem Cell Therapy. Need for Optimization of Efficacy and Safety Monitoring | |
| P478 | volume | 114 |
| Q38098248 | Adult stem cells for acute lung injury: remaining questions and concerns. |
| Q34491790 | Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: the effect of cell dosage |
| Q38499161 | Arrhythmia in stem cell transplantation |
| Q36760711 | Can the cardiomyocyte cell cycle be reprogrammed? |
| Q37273074 | Cardiac cell therapy in vitro: reproducible assays for comparing the efficacy of different donor cells |
| Q37206495 | Cell therapy for ischaemic heart disease: focus on the role of resident cardiac stem cells |
| Q36176574 | Cellular retrograde cardiomyoplasty and relaxin therapy for postischemic myocardial repair in a rat model |
| Q44069938 | Comparison of cardiac stem cells and mesenchymal stem cells transplantation on the cardiac electrophysiology in rats with myocardial infarction |
| Q37653423 | Electrophysiological challenges of cell-based myocardial repair |
| Q37640657 | Engraftment of human embryonic stem cell derived cardiomyocytes improves conduction in an arrhythmogenic in vitro model. |
| Q48555977 | Fifth Annual Mario S. Verani, MD Memorial Lecture: evolving challenges and opportunities |
| Q36206634 | Functional multipotency of stem cells: what do we need from them in the heart? |
| Q37061103 | Growth factors and cell therapy in myocardial regeneration |
| Q38636051 | Interventional Options for COPD- LVRS, Bronchoscopic Therapies and the Future |
| Q33873675 | Intramyocardial cell delivery: observations in murine hearts |
| Q35889077 | Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicine |
| Q27314502 | Mesenchymal stem cell-cardiomyocyte interactions under defined contact modes on laser-patterned biochips |
| Q35694943 | MicroRNAs Inducing Proliferation of Quiescent Adult Cardiomyocytes |
| Q51011615 | Paracrine effects of direct intramyocardial implantation of bone marrow derived cells to enhance neovascularization in chronic ischaemic myocardium. |
| Q55515618 | Platelet-Rich Plasma May Offer a New Hope in Suppressed Wound Healing When Compared to Mesenchymal Stem Cells. |
| Q40238928 | REPAIR-AMI: stem cells for acute myocardial infarction |
| Q37294044 | Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction |
| Q47347279 | Short- and long-term outcomes of intramyocardial implantation of autologous bone marrow-derived cells for the treatment of ischaemic heart disease |
| Q35776368 | Sry-type HMG box 18 contributes to the differentiation of bone marrow-derived mesenchymal stem cells to endothelial cells |
| Q39329517 | Stem Cell Therapy: A New Therapeutic Option for Cardiovascular Diseases. |
| Q50075212 | Stem Cells in Regenerative Cardiology |
| Q47376095 | Stem cell therapy trials: a call for standardization |
| Q36735379 | The continuing contribution of gene marking to cell and gene therapy. |
| Q37766123 | The paracrine effect: pivotal mechanism in cell-based cardiac repair |
| Q38390737 | The relationship between umbilical cord length and chronic rheumatic heart disease: a prospective cohort study |
| Q28068965 | Therapeutic Potential of Stem Cells Strategy for Cardiovascular Diseases |
Search more.